2:15 – 3:15 pm Saturday, October 30

Perspectives on supporting schooling for children with cancer: Findings from two PCORI Engagement Projects (230)

Education is an important social determinant of health, and treatment for childhood cancers can result in long-term neurocognitive effects (deficits in processing speed, working memory, executive function, and attention), which are associated with reduced educational attainment, employment, and ability to live independently.

Read more...
3:30 – 4:30 pm Friday, October 29

Joint Topic: AYA Health Transitions — The End of Treatment and Beyond: Integrating Components of Adolescent to Adult Healthcare Transition into Patient Care (219-2)

Survival rates for childhood cancer have greatly increased as a result of therapeutic advances. Adolescents and young adults (AYAs) are a challenging and dynamic cohort that require innovative, supportive care to foster knowledge and skills related to their cancer and healthcare transition.

Read more...
3:30 – 4:30 pm Friday, October 29

Joint Topic: AYA Health Transitions — Supporting Adolescent & Young Adult Early Survivors of Childhood Cancer Through Health Care Transitions (219-1)

Adolescents and young adults (AYAs) with cancer face unique challenges as they transition from active cancer-directed therapy to early survivorship. Developmentally at this age, the autonomy and decision-making capacity of these patients increases, and their priorities shift to a focus on issues such as school, career, and relationships.

Read more...
11:30 am – 12:30 pm Friday, October 29

Joint Topic: Developing Successful AYA and Oncofertility Programs Nuts & Bolts of Implementing an Adolescent and Young Adult (AYA) Program in the Pediatric Setting (213-1)

What have we learned over the last decade since the implementation of an Adolescent and Young Adult (AYA) Program? In this session, we will identify the unique needs of the AYA population and describe the evolving structure of our program to meet those needs.

Read more...
11:30 am – 12:30 pm Friday, October 29

Post-Transplant Lymphoproliferative Disorder: Managing the Complexities of the Pediatric Solid Organ Transplant Patient (212)

Posttransplant lymphoproliferative disorders (PTLDs) are recognized as one of the most devastating complications following solid organ transplantation. PTLD encompasses a wide range of clinical conditions—from benign lymphoproliferation to widespread malignancies with aggressive behavior. The development of PTLDs is driven by Epstein-Barr virus in the vast majority of pediatric PTLD cases.

Read more...
5:00 – 6:00 pm Thursday, October 28

“It’s my Body!”: Engaging Children and Adolescents Through Goals of Care Discussions on End of Life (206)

Childhood and adolescence are a time to navigate autonomy, yet our medical system looks to parents to make “official” decisions until children are 18 years old. The American Academy of Pediatrics recommends children and adolescents with life-limiting illnesses be provided an opportunity to participate in decisions affecting their care in a developmentally appropriate manner.

Read more...
Subscribe to this RSS feed